SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-123809
Filing Date
2023-12-06
Accepted
2023-12-06 07:04:42
Documents
14
Period of Report
2023-12-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2332263d1_8k.htm   iXBRL 8-K 25904
2 EXHIBIT 99.1 tm2332263d1_ex99-1.htm EX-99.1 19786
6 GRAPHIC tm2332263d1_ex99-1img01.jpg GRAPHIC 14764
  Complete submission text file 0001104659-23-123809.txt   244608

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vygr-20231206.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vygr-20231206_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vygr-20231206_pre.xml EX-101.PRE 22381
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2332263d1_8k_htm.xml XML 3206
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Filer) CIK: 0001640266 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37625 | Film No.: 231468404
SIC: 2836 Biological Products, (No Diagnostic Substances)